Neoptolemos JP, Kleeff J, Michl P, et al. Therapeutic developments in pancreatic cancer: current and future perspectives. Nat Rev Gastroenterol Hepatol 2018; 15(6): 333-48.
Gemenetzis G, Groot VP, Blair AB, et al. Survival in Locally Advanced Pancreatic Cancer After Neoadjuvant Therapy and Surgical Resection. Ann Surg 2019; 270(2): 340-7.
Delpero JR, Sauvanet A. Vascular Resection for Pancreatic Cancer: 2019 French Recommendations Based on a Literature Review From 2008 to 6-2019. Front Oncol 2020; 10: 40.
Article PubMed PubMed Central Google Scholar
Bockhorn M, Uzunoglu FG, Adham M, et al. Borderline resectable pancreatic cancer: a consensus statement by the International Study Group of Pancreatic Surgery (ISGPS). Surgery 2014; 155(6): 977-88.
Toomey P, Hernandez J, Morton C, et al. Resection of portovenous structures to obtain microscopically negative margins during pancreaticoduodenectomy for pancreatic adenocarcinoma is worthwhile. Am Surg 2009; 75(9): 804-9; discussion 9-10.
Navez J, Bouchart C, Lorenzo D, et al. What Should Guide the Performance of Venous Resection During Pancreaticoduodenectomy for Pancreatic Ductal Adenocarcinoma with Venous Contact? Ann Surg Oncol 2021; 28(11): 6211-22.
Article PubMed PubMed Central Google Scholar
Snyder RA, Prakash LR, Nogueras-Gonzalez GM, et al. Vein resection during pancreaticoduodenectomy for pancreatic adenocarcinoma: Patency rates and outcomes associated with thrombosis. J Surg Oncol 2018; 117(8): 1648-54.
Ramacciato G, Mercantini P, Petrucciani N, et al. Does portal-superior mesenteric vein invasion still indicate irresectability for pancreatic carcinoma? Ann Surg Oncol 2009; 16(4): 817-25.
Chen H, Turon F, Hernandez-Gea V, et al. Nontumoral portal vein thrombosis in patients awaiting liver transplantation. Liver Transpl 2016; 22(3): 352-65.
Fujii T, Nakao A, Yamada S, et al. Vein resections >3 cm during pancreatectomy are associated with poor 1-year patency rates. Surgery 2015; 157(4): 708-15.
Vuorela T, Vikatmaa P, Kokkola A, et al. Long Term Results of Pancreatectomy With and Without Venous Resection: A Comparison of Safety and Complications of Spiral Graft, End-to-End and Tangential/Patch Reconstruction Techniques. Eur J Vasc Endovasc Surg 2022; 64(2-3): 244-53.
Gao W, Dai X, Dai C, et al. Comparison of patency rates and clinical impact of different reconstruction methods following portal/superior mesenteric vein resection during pancreatectomy. Pancreatology 2016; 16(6): 1113-23.
Hackert T, Klaiber U, Hinz U, Strunk S, Loos M, Strobel O, Berchtold C, Kulu Y, Mehrabi A, Müller-Stich BP, Schneider M, Büchler MW. Portal Vein Resection in Pancreatic Cancer Surgery: Risk of Thrombosis and Radicality Determine Survival. Ann Surg 2022. https://doi.org/10.1097/SLA.0000000000005444
Bacalbasa N, Balescu I, Vilcu M, et al. Superior Mesenteric and Portal Vein Reconstruction With Cadaveric Allograft During Pancreatoduodenectomy - A Case Report and Literature Review. In Vivo 2020; 34(2): 787-91.
Article PubMed PubMed Central Google Scholar
Zhu J, Li X, Kou J, et al. Proposed Chaoyang vascular classification for superior mesenteric-portal vein invasion, resection, and reconstruction in patients with pancreatic head cancer during pancreaticoduodenectomy - A retrospective cohort study. Int J Surg 2018; 53: 292-7.
Yerdel MA, Gunson B, Mirza D, et al. Portal vein thrombosis in adults undergoing liver transplantation: risk factors, screening, management, and outcome. Transplantation 2000; 69(9): 1873-81.
Article CAS PubMed Google Scholar
Jemal A, Siegel R, Ward E, et al. Cancer statistics, 2008. CA Cancer J Clin 2008; 58(2): 71-96.
Sener SF, Fremgen A, Menck HR, et al. Pancreatic cancer: a report of treatment and survival trends for 100,313 patients diagnosed from 1985-1995, using the National Cancer Database. J Am Coll Surg 1999; 189(1): 1-7.
Article CAS PubMed Google Scholar
Moore GE, Sako Y, Thomas LB. Radical pancreatoduodenectomy with resection and reanastomosis of the superior mesenteric vein. Surgery 1951; 30(3): 550-3.
Glebova NO, Hicks CW, Piazza KM, et al. Technical risk factors for portal vein reconstruction thrombosis in pancreatic resection. J Vasc Surg 2015; 62(2): 424-33.
Kang MJ, Jang JY, Chang YR, et al. Portal vein patency after pancreatoduodenectomy for periampullary cancer. Br J Surg 2015; 102(1): 77-84.
Article CAS PubMed Google Scholar
Ouaissi M, Sielezneff I, Pirro N, et al. Therapeutic anticoagulant does not modify thromboses rate vein after venous reconstruction following pancreaticoduodenectomy. Gastroenterol Res Pract 2008; 2008: 896320.
Article PubMed PubMed Central Google Scholar
Smoot RL, Christein JD, Farnell MB. Durability of portal venous reconstruction following resection during pancreaticoduodenectomy. J Gastrointest Surg 2006; 10(10): 1371-5.
Chu CK, Farnell MB, Nguyen JH, et al. Prosthetic graft reconstruction after portal vein resection in pancreaticoduodenectomy: a multicenter analysis. J Am Coll Surg 2010; 211(3): 316-24.
Sgroi MD, Narayan RR, Lane JS, et al. Vascular reconstruction plays an important role in the treatment of pancreatic adenocarcinoma. J Vasc Surg 2015; 61(2): 475-80.
Roch AM, Kilbane EM, Nguyen T, et al. Portal Vein Thrombosis After Venous Reconstruction During Pancreatectomy: Timing and Risks. J Gastrointest Surg 2022; 26(10): 2148-57.
Tripodi A, Branchi A, Chantarangkul V, et al. Hypercoagulability in patients with type 2 diabetes mellitus detected by a thrombin generation assay. J Thromb Thrombolysis 2011; 31(2): 165-72.
Article CAS PubMed Google Scholar
Bai J, Ding X, Du X, et al. Diabetes is associated with increased risk of venous thromboembolism: a systematic review and meta-analysis. Thromb Res 2015; 135(1): 90-5.
Article CAS PubMed Google Scholar
Andersen DK, Korc M, Petersen GM, et al. Diabetes, Pancreatogenic Diabetes, and Pancreatic Cancer. Diabetes 2017; 66(5): 1103-10.
Article CAS PubMed PubMed Central Google Scholar
Menini S, Iacobini C, Vitale M, Pesce C, Pugliese G. Diabetes and Pancreatic Cancer-A Dangerous Liaison Relying on Carbonyl Stress. Cancers (Basel) 2021; 13(2):313. https://doi.org/10.3390/cancers13020313
Batabyal P, Vander Hoorn S, Christophi C, et al. Association of diabetes mellitus and pancreatic adenocarcinoma: a meta-analysis of 88 studies. Ann Surg Oncol 2014; 21(7): 2453-62.
Lu Y, Garcia Rodriguez LA, Malgerud L, et al. New-onset type 2 diabetes, elevated HbA1c, anti-diabetic medications, and risk of pancreatic cancer. Br J Cancer 2015; 113(11): 1607-14.
Article CAS PubMed PubMed Central Google Scholar
Meniconi RL, Santoro R, Guglielmo N, et al. Pancreaticoduodenectomy with venous reconstruction using cold-stored vein allografts: long-term results of a single center experience. J Hepatobiliary Pancreat Sci 2016; 23(1): 43-9.
Ren Z, Cui S, Lyu S, et al. Establishment of rat allogenic vein replacement model and pathological characteristics of the replaced vessels. Front Surg 2022; 9: 984959.
Article PubMed PubMed Central Google Scholar
Sano M, Takahashi R, Ijichi H, et al. Blocking VCAM-1 inhibits pancreatic tumour progression and cancer-associated thrombosis/thromboembolism. Gut 2021; 70(9): 1713-23.
Article CAS PubMed Google Scholar
Oto J, Navarro S, Larsen AC, Solmoirago MJ, Plana E, Hervás D, Fernández-Pardo Á, España F, Kristensen SR, Thorlacius-Ussing O, Medina P. MicroRNAs and Neutrophil Activation Markers Predict Venous Thrombosis in Pancreatic Ductal Adenocarcinoma and Distal Extrahepatic Cholangiocarcinoma. Int J Mol Sci 2020; 21(3):840. https://doi.org/10.3390/ijms21030840
Settmacher U, Nussler NC, Glanemann M, et al. Venous complications after orthotopic liver transplantation. Clin Transplant 2000; 14(3): 235-41.
Comments (0)